HIMS Insider Filing: RSU Grants and 6,500-Share Tax Withholding Reported
Rhea-AI Filing Summary
Patrick Harrison Carroll, Chief Medical Officer and director of Hims & Hers Health, Inc. (HIMS), reported transactions dated 09/15/2025 on Form 4. He was granted 16,521 RSUs that convert one-for-one into Class A common stock and additional RSU awards listed in the filing totaling 16,521 + 8,148 + 4,840 + 3,533 units across entries. The issuer withheld 6,500 shares to satisfy tax withholding at a reported price of $53.96, reducing reported Class A common stock beneficial ownership from 186,461 to 179,961 following the withholding. The RSUs are subject to service-based vesting schedules, generally over four years with quarterly vesting dates specified in the filing.
The filing is a reporting of equity awards and related withholding; it documents grant mechanics, vesting schedules, and post-transaction beneficial ownership levels but does not provide compensation totals in dollars beyond the withholding price or other company financial metrics.
Positive
- RSU grants disclosed showing alignment of executive compensation with equity ownership
- Detailed vesting schedules provided, specifying quarterly vesting over a four-year period
Negative
- 6,500 shares withheld by the issuer to satisfy tax withholding, reducing direct beneficial ownership from 186,461 to 179,961
- Form 4 contains no cash compensation totals or dollar-value aggregation of the awards beyond the withholding price
Insights
TL;DR: Routine RSU grants and tax-withholding reported; modest change in beneficial ownership, no cash proceeds or open-market sales disclosed.
The Form 4 documents service-based Restricted Stock Unit grants to an executive who is also a director, with vesting schedules over four years and quarterly vesting dates. The issuer withheld 6,500 shares to cover tax obligations at a stated price of $53.96, and the reporting persons reported direct Class A common stock decreased from 186,461 to 179,961 shares following withholding. The filing contains no information about exercise of options for cash, open-market dispositions, or additional compensation cash amounts.
TL;DR: Disclosure shows standard equity compensation mechanics and tax withholding; vesting schedules and insider status are clearly disclosed.
The reporting person is identified as both Chief Medical Officer and a director, and the Form 4 details multiple RSU grants with explicit service-based vesting schedules (4-year terms with quarterly vesting dates). The filing clearly states that RSUs convert one-for-one to Class A common stock and that shares were withheld for tax withholding. This is a routine insider disclosure consistent with equity-based compensation and Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 8,148 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 4,840 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 3,533 | $0.00 | -- |
| Exercise | Class A Common Stock | 16,521 | $0.00 | -- |
| Tax Withholding | Class A Common Stock | 6,500 | $53.96 | $351K |
Footnotes (1)
- The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
